Loading cancer entity…
Loading cancer entity…
Clinical trials
35 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (7)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03134872 | A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC | completed | Phase 3 | 419 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jun 9, 2020 | clinicaltrials |
| NCT03331588 | Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung Cancer | completed | Phase 3 | 200 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | Mar 2, 2020 |
| NCT00652769 | A New Pathway With BronchOscopic or Oesophageal Ultrasound for Lung Cancer Diagnosis and STaging (BOOST)(BOOST) | completed | Phase 3 | 168 | University College London HospitalsOTHER | 1 | Nov 1, 2017 | clinicaltrials |
Data updated 22 days agoSource updated Jun 9, 2020source: clinicaltrials